Del Bufalo D - Search Results

1

Bcl-xL: A Focus on Melanoma Pathobiology.

Lucianò AM, Pérez-Oliva AB, Mulero V, Del Bufalo D. Lucianò AM, et al. Among authors: del bufalo d. Int J Mol Sci. 2021 Mar 9;22(5):2777. doi: 10.3390/ijms22052777. Int J Mol Sci. 2021. PMID: 33803452 Free PMC article. Review.

2

bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells.

Biroccio A, Del Bufalo D, Fanciulli M, Bruno T, Zupi G, Floridi A. Biroccio A, et al. Among authors: del bufalo d. Int J Cancer. 1999 Jul 2;82(1):125-30. doi: 10.1002/(sici)1097-0215(19990702)82:1<125::aid-ijc21>3.0.co;2-q. Int J Cancer. 1999. PMID: 10360831 Free article.

3

c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.

Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G. Biroccio A, et al. Among authors: del bufalo d. Mol Pharmacol. 2001 Jul;60(1):174-82. doi: 10.1124/mol.60.1.174. Mol Pharmacol. 2001. PMID: 11408612

4

Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.

Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D. Iervolino A, et al. Among authors: del bufalo d. FASEB J. 2002 Sep;16(11):1453-5. doi: 10.1096/fj.02-0122fje. Epub 2002 Jul 1. FASEB J. 2002. PMID: 12205045

5

Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.

Del Bufalo D, Trisciuoglio D, Scarsella M, Zangemeister-Wittke U, Zupi G. Del Bufalo D, et al. Oncogene. 2003 Nov 20;22(52):8441-7. doi: 10.1038/sj.onc.1206999. Oncogene. 2003. PMID: 14627985

6

Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.

Milella M, Trisciuoglio D, Bruno T, Ciuffreda L, Mottolese M, Cianciulli A, Cognetti F, Zangemeister-Wittke U, Del Bufalo D, Zupi G. Milella M, et al. Among authors: del bufalo d. Clin Cancer Res. 2004 Nov 15;10(22):7747-56. doi: 10.1158/1078-0432.CCR-04-0908. Clin Cancer Res. 2004. PMID: 15570009

7

Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.

Trisciuoglio D, Desideri M, Ciuffreda L, Mottolese M, Ribatti D, Vacca A, Del Rosso M, Marcocci L, Zupi G, Del Bufalo D. Trisciuoglio D, et al. Among authors: del rosso m, del bufalo d. J Cell Physiol. 2005 Dec;205(3):414-21. doi: 10.1002/jcp.20413. J Cell Physiol. 2005. PMID: 15920759

8

Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells.

Trisciuoglio D, Iervolino A, Zupi G, Del Bufalo D. Trisciuoglio D, et al. Among authors: del bufalo d. Mol Biol Cell. 2005 Sep;16(9):4153-62. doi: 10.1091/mbc.e04-12-1087. Epub 2005 Jun 29. Mol Biol Cell. 2005. PMID: 15987743 Free PMC article.

9

Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression.

Giorgini S, Trisciuoglio D, Gabellini C, Desideri M, Castellini L, Colarossi C, Zangemeister-Wittke U, Zupi G, Del Bufalo D. Giorgini S, et al. Among authors: del bufalo d. Mol Cancer Res. 2007 Aug;5(8):761-71. doi: 10.1158/1541-7786.MCR-07-0088. Mol Cancer Res. 2007. PMID: 17699103

10

Involvement of nuclear factor-kappa B in bcl-xL-induced interleukin 8 expression in glioblastoma.

Gabellini C, Castellini L, Trisciuoglio D, Kracht M, Zupi G, Del Bufalo D. Gabellini C, et al. Among authors: del bufalo d. J Neurochem. 2008 Nov;107(3):871-82. doi: 10.1111/j.1471-4159.2008.05661.x. Epub 2008 Sep 11. J Neurochem. 2008. PMID: 18786178 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page